Related Experiment Video
Updated: Aug 6, 2026
Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Published on: June 20, 2015
Nanotechnology-enabled precision targeting of lung cancer stem cells: Recent developments and therapeutic
Yi Zhang1,2, Jiaxin Fan3, Yuhan Ye4
1Department of Medical Oncology, Affiliated Zhongshan Hospital of Dalian University, Dalian, Liaoning, 116001, China.
Abstract:
Lung cancer remains one of the leading causes of cancer-related mortality worldwide, highlighting the urgent need for more effective therapeutic strategies. Lung cancer stem cells (LCSCs) play critical roles in tumor initiation, metastasis, therapeutic resistance, and recurrence through dynamic interactions with the tumor microenvironment (TME), metabolic reprogramming, and immune evasion. Despite advances in targeted therapy and immunotherapy, conventional approaches remain insufficient for the complete elimination of LCSCs. Recent progress in nanotechnology has provided new opportunities for precision targeting of LCSCs by enhancing drug bioavailability, tumor selectivity, controlled release, and multifunctional therapeutic integration. In this review, we summarize current nanotechnology-enabled strategies targeting LCSCs, with particular emphasis on TME remodeling, metabolic regulation, and tumor immunity. Distinct from previous reviews that discuss cancer stem cells or nanomedicine separately, this review establishes an integrated framework linking LCSC niche regulation with nanotechnology-based precision therapeutics in lung cancer. We further highlight the therapeutic potential of multifunctional nanoplatforms, including nanocrystalline drugs, smart nanocarriers, and combinational nano-delivery systems, in modulating stemness-associated pathways, overcoming immune suppression, and disrupting metabolic adaptation. In addition, emerging strategies involving stimulus-responsive nanomaterials, ferroptosis induction, and engineered immunotherapeutic platforms are discussed. Finally, current challenges and future perspectives regarding tumor heterogeneity, nanocarrier biocompatibility, translational feasibility, and personalized therapeutic design are addressed. Collectively, this review provides a comprehensive perspective on nanotechnology-enabled precision targeting of LCSCs and offers insights into next-generation therapeutic strategies for lung cancer.
Insights
Nanotechnology offers precision targeting for lung cancer stem cells (LCSCs), addressing therapeutic resistance and recurrence. This review integrates LCSC niche regulation with nanomedicine for advanced lung cancer treatment strategies.
Area of Science:
- Oncology
- Nanotechnology
- Biomedical Engineering
Background:
- Lung cancer is a leading cause of cancer mortality, with lung cancer stem cells (LCSCs) driving tumor progression and treatment failure.
- Current therapies struggle to eradicate LCSCs due to their role in metastasis, resistance, and recurrence.
- The tumor microenvironment (TME) significantly influences LCSC behavior, including metabolic reprogramming and immune evasion.
Purpose of the Study:
- To review nanotechnology-enabled strategies for precision targeting of LCSCs in lung cancer.
- To establish an integrated framework linking LCSC niche regulation with nanomedicine.
- To highlight the potential of multifunctional nanoplatforms in overcoming therapeutic challenges.
Main Methods:
- Review of current literature on nanotechnology applications for LCSC targeting.
- Analysis of strategies for TME remodeling, metabolic regulation, and immune modulation using nanomedicine.
- Discussion of multifunctional nanoplatforms and emerging therapeutic approaches.
Main Results:
- Nanotechnology enhances drug delivery, selectivity, and controlled release for LCSCs.
- Multifunctional nanoplatforms can modulate stemness pathways, immune suppression, and metabolic adaptation.
- Emerging strategies include stimulus-responsive nanomaterials, ferroptosis induction, and engineered immunotherapeutics.
Conclusions:
- Nanotechnology provides a promising avenue for precision targeting of LCSCs, improving lung cancer treatment efficacy.
- Integrated approaches combining LCSC niche regulation and nanomedicine offer next-generation therapeutic potential.
- Addressing challenges like tumor heterogeneity and translational feasibility is crucial for clinical application.
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...